Generic Antineoplastic / Chemotherapeutic agent / Anthracyclines
Generic Antineoplastic / Chemotherapeutic agent / Anthracyclines Companies (3)
Generic Antineoplastic / Chemotherapeutic agent / Anthracyclines News
-
News Novartis agrees for copies to be made of cancer drug to reach poorer countries
Novartis signs agreement with MPP to have generics of it's leukemia drug made so that it can be more easily distributed to the world's poorer countries.
Generic Antineoplastic / Chemotherapeutic agent / Anthracyclines Products (13)
-
Product APIs
• Paclitaxel (Package : Up to 500g Per request) • Pemetrexed (Package : Up to 1kg Per request) • Bortezomib (Package : Up to 40g Per request) -
Product Fulvestrant
Indicated for the treatment of Hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced breast cancer in postmenopausal women not previously treated with endocrine therapy, or HR-positive advanced breast cancer in postmenopausal women with disease progression... -
Product Oncology API# Bulk Sterile # General API
ONCOLOGY : Cytarabine Gemcitabine Pemetrexate Paclitaxel Letrozole Irrinotecane Bicalutamide Gefitinib Etoposide Anastrazole Dacarbazine Bulk Sterile : Methyle prednisolone Hydrocortisone Pantoprazole Chloramphenicol Colistimethate Polymyxin B Gluthatione General API Suxamethonium Ropivaccaine Neostigmine... -
Product CDMO
• Cytotoxic Injection (Liquid , Lyophilized) • ONCOLOGY • CYTOTOXIC API • EU GMP • JGMP (Japan) • KGMP (Korea) • PIC/S -
Product Erdafitinib
Indicated for the treatment of adult patients with locally advanced or metastatic urothelial carcinoma (mUC), that has susceptible FGFR3 or FGFR2 genetic alterations, and progressed during or following at least one line of prior platinum-containing chemotherapy, including within 12 months of neoadjuva... -
Product Binimetinib
Indicated, in combination with encorafenib, for the treatment of patients with unresectable or metastatic melanoma with a BRAF V600E or V600K mutation -
Product Midostaurin
Indicated, in combination with standard cytarabine and daunorubicin induction and cytarabine consolidation chemotherapy, for the treatment of adult patients with newly diagnosed acute myeloid leukemia (AML) who are FLT3 mutation-positive, as detected by a FDA approved test -
Product Ixazomib Citrate
Indicated in combination with lenalidomide and dexamethasone for the treatment of patients with multiple myeloma who have received at least one prior therapy. -
Product Everolimus
Indicated for Prophylaxis of Organ Rejection in Kidney Transplantation and Prophylaxis of Organ Rejection in Liver Transplantation -
Product CDMO injectable oncology
Cytopharma is a contract development and manufacturing organization (CDMO) that has quickly built a reputation for excellence based on its sterile expertise, innovation and high quality products. Cytopharma has a track record of successful development and launches of more than 20 cytotoxic product. Cytopha... -
Product INJECTIONS
Albumin bound Paclitaxel Inj Azacitadine Inj Bendamustin Inj Bortezomib Inj Busulfan Inj Carboplatin Inj Carfilzomib Inj Carmustin Inj Cisplatin Inj Cytrabine Inj Dacarbazine Inj Dactinomycin Inj Degrarelix Inj Doceteaxel Inj Doxorubicin Inj Epirubicin Inj Eribulin Inj Etoposide Inj Fludarabine Inj Fosapre... -
Product GEMCITABINA 200mg y 1 G
Fabricado por FARMACO URUGUAYO empresa de la Corporación MEDIFARMA, Planta de manufactura de productos Oncologicos en Uruguay, Certificada por ANVISA de Brasil, CECMED de Cuba, DIGEMID de Perú y MSP de Uruguay, con exportacion a mas de 12 paises de America.
Manufa...
Upcoming Events
-
CPHI Middle East 2024
Riyadh Front Exhibition & Convention Center Riyadh, Saudi Arabia
10 Dec 2024 - 12 Dec 2024 -
Pharmapack Europe 2025
Paris Expo, Porte de Versailles - Hall 7.2 | Paris, France
22 Jan 2025 - 23 Jan 2025 -
CPHI Japan 2025
East Halls 4, 5 & 6, Tokyo Big Sight, Tokyo, Japan
09 Apr 2025 – 11 Apr 2025
Pharmaceutical Industry Webinars
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance